1-7 of 7
Shu-Hsia Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Influencing Factors and Predictors for Bleeding Outcomes in Severe-Type People with Hemophilia a (PwHA) on Extended Half-Life rFVIII-Fc Prophylaxis

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Chao-Neng CHENG, Yen-Lin Liu, Chen-Hua Tsai, Jia-Ruey Tsai, Wan-Ling Ho, Shu-Hsia Hu, Yeu-Chin Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 5491.
https://doi.org/10.1182/blood-2024-209472
Published: 2024
Journal Articles

Factor VIII (FVIII) Trough Levels of Real-World Severe-Type People with Hemophilia a (PwHA) on rFVIII-Fc Prophylaxis: Clinical Correlates and Effects on Perceivable Bleeding Outcomes

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Yen-Lin Liu, Jia-Ruey Tsai, Chen-Hua Tsai, Wan-Ling Ho, Chao-Neng CHENG, Shu-Hsia Hu, Yeu-Chin Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 3966.
https://doi.org/10.1182/blood-2024-200872
Published: 2024
Journal Articles

The Impacts of Genetic Polymorphisms on the Von Willebrand Factor Level in Type 1 Von Willebrand Disease

Yeu-Chin Chen, Chia-Yau Chang, Shin-Nan Cheng, Shiue-Wei Lai, Shu-Hsia Hu
Journal: Blood
Blood (2023) 142 (Supplement 1): 286.
https://doi.org/10.1182/blood-2023-180681
Published: 2023
Journal Articles

Baseline VWF:Ag Level and Body Mass Index Are Inverse Influencing Factors of Annualized Total Bleeding Rate and Annualized Joint Bleeding Rate Respectively in Severe-Type Adult Patients with Hemophilia a (PwHA) with Episodic Treatment with rFVIII

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Jung-Tzu Ku, Shu-Hsia Hu, Jia-Ruey Tsai, Chen-Hua Tsai, Pei-Yi Lai, Yen-Lin Liu, Chao-Neng Cheng, Yeu-Chin Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3199.
https://doi.org/10.1182/blood-2021-150822
Published: 2021
Journal Articles

Real-World Bleeding Outcomes, Weekly Factor Consumption Doses, Annualized Factor Costs in Severe-Type Patients with Hemophilia a (PwHA) before and after Switching to Extended Half-Life rFVIII-Fc Prophylaxis

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Pei-Yi Lai, Jung-Tzu Ku, Shu-Hsia Hu, Chen-Hua Tsai, Chao-Neng Cheng, Yen-Lin Liu, Jia-Ruey Tsai, Yeu-Chin Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 3198.
https://doi.org/10.1182/blood-2021-152066
Published: 2021
Journal Articles

Clinical Predictors and Prediction Models for Frequency of Total and Joint Hemorrhage in Severe-Type Patients with Hemophilia a (PwHA) with/without Intermediate-Dose Prophylaxis Therapy with rFVIII

Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Jung-Tzu Ku, Shu-Hsia Hu, Chen-Hua Tsai, Pei-Yi Lai, Yen-Lin Liu, Jia-Ruey Tsai, Chao-Neng Cheng, Yeu-Chin Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 1047.
https://doi.org/10.1182/blood-2021-147069
Published: 2021
Journal Articles

The Real-World Experience of rFVIII-Fc Used in Hemophilia a Patients in Taiwan: Prophylaxis Rates, Pharmacokinetics and Clinical Correlates, and the Effects on Joint Health

Chia-Yau Chang, MD, Yeu-Chin Chen, MD, Chen-Hua Tsai, MD, Jia-Ruey Tsai, MD, Yen-Lin Liu, MD, Shu-Hsia Hu
Journal: Blood
Blood (2019) 134 (Supplement_1): 2406.
https://doi.org/10.1182/blood-2019-132137
Published: 2019